Dr Naomi Walsh
Senior Council Member
Dr. Naomi Walsh completed her PhD in Cancer Research from Dublin City University in 2008, and was awarded outstanding graduate researcher award from DCU’s Faculty of Science & Health. She also holds a Masters of Public Health (MPH) from University College Dublin. She conducted her post-doctoral research as a Cancer Prevention Fellow at the National Cancer Institute, USA. Upon her return to Ireland in 2015, Dr. Walsh held the HRB/Irish Cancer Society Cancer Prevention Fellow in the National Institute for Cellular Biotechnology, DCU. Subsequently, she received a Science Foundation Ireland Starter Investigator Research Grant (2016-2020) and established her research group. In 2017, she was awarded the Irish Cancer Society researcher of the year.
Dr. Walsh’s current research is focused on developing organotypic 3D cancer models to define and validate the biological consequences of genomic variants of pancreatic cancer. Her research aims to understand the development of pancreatic cancer, to uncover markers for early detection and to identify those at high risk of pancreatic cancer. Other interests include understanding the tumour diversity caused by genomic alterations which contributes to cancer resistance to chemotherapy and molecular targeted therapies in breast and melanoma. Her lab uses genomic and functional NGS approaches to identify the mechanisms of genomic and immunological diversity to develop prognostic/predictive signatures and therapeutic strategies to overcome treatment resistance.
3D mammosphere culture of breast epithelial cell line MCF10A.
Courtesy of Dr. Emer Bourke, NUI Galway.
Phospho-Akt expression and localisation
Mediated by VEGF in A549 lung cancer cells
Metaphase chromosome spread of Jurkat T-lymphoma cells
Apoptosis assessment of SKMES-1 lung cancer cells
Using a multiparameter apoptosis staining kit, showing cell nuclei (blue), actin (green) and mitochondrial activity (orange).
Mitotic Chronic Myelogenous Leukaemia K562 Cells
Cell to Cell Tweeting
Via nanoparticles (red) in Triple Negative Breast Cancer (TNBC)
Courtesy of Sinéad Lindsay, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin (UCD) Ireland.
Confocal microscopy analysis
Of phospho-Akt expression in H460 lung cancer cells in response to hypoxia (0.5% O2).
What's On? IACR 2023 Agenda
Download the initial draft of the IACR BioMedical agenda for our 59th Annual Conference.
Registration/ Membership for IACR 2023
Registration for the 59th Annual Conference in the Radisson Blu hotel, Athlone is Now Open.
EACR Membership is Included
The IACR is an affiliated national society and its members benefit from full membership of the EACR.
Late Breaking Abstracts in Now OPEN!
Biomedical Session Abstracts
Deadline: Midnight, Friday, 20th January 2023
- Patrick Johnston Lay submission category is now closed
- Late Breaking Abstracts submitted to the Biomedical Sessions will be considered for Display Poster Presentation.
Social Nursing and Allied Health (SNAH) Abstracts
Deadline: Midnight, Monday, 9th January 2023
SNAH abstract submissions will remain open until Monday 9th January.
Please contact Sinead on: firstname.lastname@example.org
Irish Association for Cancer Research (IACR) is a registered charity on the Register of Charitable Organisations.
Registered Charity Number (RCN): 20030117